Last edition
News about "Chiesi Farmaceutici "
Gossamer Bio Partners with Chiesi to Develop and Commercialize Seralutinib
Gossamer Bio, Inc. has signed a global collaboration and license deal with Chiesi Farmaceutici to develop and commercialize seralutinib.
Chiesi Farmaceutici | 07/05/2024 | By Aishwarya | 359
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members